Status:
TERMINATED
Minimally Invasive Detection of a Sleep Apnoea
Lead Sponsor:
Erasme University Hospital
Conditions:
Sleep Disorder; Breathing-Related
Cardiovascular Diseases
Eligibility:
All Genders
18-70 years
Brief Summary
Obstructive sleep apnoea (OSA) is characterised by recurrent nocturnal respiratory interruptions, resulting from the total or partial collapse of the upper respiratory ways. This results into sleep fr...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Men and women 18-70 years old
- Exclusion Criteria (group A):
- Cardiorespiratory co-morbidities
- Exclusion Criteria (groups B-C-D):
- BMI\>35 kg/m2
- Moderate, severe valvular disease
- Permanent atrial fibrillation or frequent premature contractions
- Atrio-ventricular conduction disturbances
- Medications which reduces heart rate and heart rate variability
- Cardiac rhythm driven by a pacemaker
- Systolic heart failure of any origin (ischaemic, dilatated ect..)
- Neurological diseases responsible for abnormal movements
- Denied participation
Exclusion
Key Trial Info
Start Date :
November 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT03760159
Start Date
November 1 2018
End Date
June 30 2020
Last Update
April 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sofia Morra
Brussels, Belgium, 1070